Portfolio Holdings Detail for ISIN IE00B3VWM098

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE

Holdings detail for NUVL

Show aggregate NUVL holdings

News associated with NUVL

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Buy” from Analysts

Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) has earned an average recommendation of “Buy” from the eleven ratings firms that are covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among […] - 2025-08-29 02:14:49

Piper Sandler Begins Coverage on Nuvalent (NASDAQ:NUVL)

Equities research analysts at Piper Sandler initiated coverage on shares of Nuvalent (NASDAQ:NUVL – Get Free Report) in a note issued to investors on Tuesday, MarketBeat.com reports. The brokerage set an “overweight” rating and a $112.00 price target on the stock. Piper Sandler’s price target indicates a potential upside of 52.92% from the stock’s previous […] - 2025-08-21 04:24:45

Nuvalent, Inc. (NASDAQ:NUVL) Shares Sold by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. trimmed its holdings in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 2.3% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 6,520 shares of the company’s stock after selling 153 shares during the period. Envestnet Asset Management Inc.’s holdings in Nuvalent were worth $462,000 as of its most […] - 2025-08-07 05:02:59

Universal Beteiligungs und Servicegesellschaft mbH Sells 11,308 Shares of Nuvalent, Inc. (NASDAQ:NUVL)

Universal Beteiligungs und Servicegesellschaft mbH cut its stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 20.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,255 shares of the company’s stock after selling 11,308 shares during the quarter. Universal Beteiligungs und […] - 2025-07-29 05:26:54

Head to Head Analysis: Nuvalent (NASDAQ:NUVL) vs. OnKure Therapeutics (NASDAQ:OKUR)

OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) and Nuvalent (NASDAQ:NUVL – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations. Analyst Ratings This is a breakdown of recent recommendations […] - 2025-07-25 05:56:58

Nuvalent (NASDAQ:NUVL) Given “Outperform” Rating at Wedbush

Wedbush reiterated their outperform rating on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research report sent to investors on Monday,RTT News reports. The brokerage currently has a $115.00 price target on the stock. NUVL has been the subject of a number of other reports. HC Wainwright reiterated a “buy” rating and set a […] - 2025-07-22 07:10:52

Henry E. Pelish Sells 5,500 Shares of Nuvalent, Inc. (NASDAQ:NUVL) Stock

Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) insider Henry E. Pelish sold 5,500 shares of the firm’s stock in a transaction dated Thursday, July 10th. The stock was sold at an average price of $79.98, for a total transaction of $439,890.00. Following the completion of the transaction, the insider owned 60,956 shares in the company, […] - 2025-07-14 05:12:52

The Goldman Sachs Group Upgrades Nuvalent (NASDAQ:NUVL) to Strong-Buy

The Goldman Sachs Group upgraded shares of Nuvalent (NASDAQ:NUVL – Free Report) to a strong-buy rating in a research report report published on Monday morning,Zacks.com reports. A number of other research firms also recently issued reports on NUVL. Leerink Partners increased their price target on shares of Nuvalent from $125.00 to $140.00 and gave the […] - 2025-07-03 03:01:05

HC Wainwright Forecasts Strong Price Appreciation for Nuvalent (NASDAQ:NUVL) Stock

Nuvalent (NASDAQ:NUVL – Get Free Report) had its price target boosted by analysts at HC Wainwright from $110.00 to $130.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 64.37% from the company’s previous close. Separately, UBS Group […] - 2025-06-26 03:13:07

SG Americas Securities LLC Has $989,000 Holdings in Nuvalent, Inc. (NASDAQ:NUVL)

SG Americas Securities LLC grew its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 29.2% during the 1st quarter, Holdings Channel.com reports. The firm owned 13,946 shares of the company’s stock after purchasing an additional 3,153 shares during the period. SG Americas Securities LLC’s holdings in Nuvalent were worth $989,000 as of its most […] - 2025-06-18 05:56:50

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 4.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,047 shares of the company’s stock after acquiring an additional 1,273 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Nuvalent were […] - 2025-05-22 05:52:58

Northern Trust Corp Buys 15,770 Shares of Nuvalent, Inc. (NASDAQ:NUVL)

Northern Trust Corp grew its stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 4.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 335,550 shares of the company’s stock after purchasing an additional 15,770 shares during the period. Northern Trust Corp owned approximately […] - 2025-05-12 05:42:54

First Trust Advisors LP Raises Stake in Nuvalent, Inc. (NASDAQ:NUVL)

First Trust Advisors LP lifted its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,542 shares of the company’s stock after purchasing an additional 1,685 shares during the period. […] - 2025-05-04 05:30:55

Nuvalent, Inc. (NASDAQ:NUVL) Shares Bought by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC increased its holdings in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,618 shares of the company’s stock after purchasing an additional 309 shares during the period. […] - 2025-04-11 04:28:50

Sei Investments Co. Has $549,000 Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL)

Sei Investments Co. trimmed its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 44.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 7,016 shares of the company’s stock after selling 5,659 shares during the period. Sei Investments Co.’s holdings in Nuvalent were worth $549,000 as of its most recent filing with […] - 2025-04-10 04:18:52

Corebridge Financial Inc. Decreases Stake in Nuvalent, Inc. (NASDAQ:NUVL)

Corebridge Financial Inc. lessened its position in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 5.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,472 shares of the company’s stock after selling 1,051 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-04 05:41:03

US Bancorp DE Makes New $90,000 Investment in Nuvalent, Inc. (NASDAQ:NUVL)

US Bancorp DE acquired a new stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,156 shares of the company’s stock, valued at approximately $90,000. A number of other hedge funds have also modified […] - 2025-03-18 05:12:56

Nuvalent, Inc. (NASDAQ:NUVL) Holdings Lifted by abrdn plc

abrdn plc raised its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 19.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,701 shares of the company’s stock after purchasing an additional 9,241 shares during the quarter. abrdn plc owned about 0.08% of Nuvalent […] - 2025-02-10 16:42:58

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc NUVL holdings

Date	Number of NUVL Shares Held	Base Market Value of NUVL Shares	Local Market Value of NUVL Shares	Change in NUVL Shares Held	Change in NUVL Base Value	Current Price per NUVL Share Held	Previous Price per NUVL Share Held
2025-09-26 (Friday)	4,311	USD 350,872	USD 350,872
2025-09-25 (Thursday)	4,311	USD 334,189	USD 334,189	0	USD -8,708	USD 77.5201	USD 79.54
2025-09-24 (Wednesday)	4,311	USD 342,897	USD 342,897
2025-09-17 (Wednesday)	4,283	USD 336,815	USD 336,815	0	USD 1,328	USD 78.64	USD 78.3299
2025-09-16 (Tuesday)	4,283	USD 335,487	USD 335,487
2025-09-12 (Friday)	4,255	USD 342,400	USD 342,400
2025-09-11 (Thursday)	4,255	USD 349,846	USD 349,846

Share Trades of NUVL by Blackrock for IE00B3VWM098

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-08-21	SELL	-14			73.650*		79.70 Profit of 1,116 on sale
2025-07-31	BUY	42			78.350*		79.75
2025-06-30	SELL	-28			76.300*		79.59 Profit of 2,228 on sale
2025-06-25	SELL	-14			79.090*		79.59 Profit of 1,114 on sale
2025-06-20	SELL	-28			75.000*		79.67 Profit of 2,231 on sale
2025-05-23	BUY	14			73.490*		80.28
2025-05-19	SELL	-14			73.310*		80.50 Profit of 1,127 on sale
2025-05-15	SELL	-42			71.000*		80.64 Profit of 3,387 on sale
2025-05-12	SELL	-14			73.630*		80.88 Profit of 1,132 on sale
2025-05-09	SELL	-14			69.850*		80.98 Profit of 1,134 on sale
2025-04-30	SELL	-14			76.750*		81.51 Profit of 1,141 on sale
2025-04-24	SELL	-28			73.980*		81.78 Profit of 2,290 on sale
2025-04-17	SELL	-14			71.640*		82.33 Profit of 1,153 on sale
2025-04-15	SELL	-42			70.780*		82.59 Profit of 3,469 on sale
2025-04-14	SELL	-42			70.000*		82.73 Profit of 3,475 on sale
2025-04-09	SELL	-56			64.700*		83.36 Profit of 4,668 on sale
2025-04-07	SELL	-98			64.680*		83.85 Profit of 8,218 on sale
2025-04-04	SELL	-140			65.740*		84.07 Profit of 11,770 on sale
2025-03-31	BUY	14			70.920*		84.59
2025-03-19	SELL	-28			77.570*		85.55 Profit of 2,395 on sale
2025-03-14	SELL	-84			77.010*		85.91 Profit of 7,217 on sale
2025-03-13	SELL	-28			74.480*		86.08 Profit of 2,410 on sale
2025-03-12	SELL	-476			72.520*		86.27 Profit of 41,066 on sale
2025-03-07	SELL	-28			71.070*		87.03 Profit of 2,437 on sale
2025-03-06	SELL	-42			72.940*		87.25 Profit of 3,664 on sale
2025-03-03	SELL	-14			71.030*		88.01 Profit of 1,232 on sale
2025-02-28	SELL	-84			74.980*		88.22 Profit of 7,411 on sale
2025-02-26	SELL	-14			77.040*		88.64 Profit of 1,241 on sale
2025-02-25	SELL	-42			75.890*		88.86 Profit of 3,732 on sale
2025-02-18	BUY	70			79.190*		89.71
2025-02-13	BUY	14			80.950*		90.35
2025-02-12	BUY	14			81.240*		90.54
2025-02-11	BUY	42			82.900*		90.70
2025-02-06	BUY	126			86.700*		91.06
2025-01-27	BUY	14			82.590*		92.19
2024-12-30	BUY	70			77.870*		93.55
2024-12-06	BUY	56			94.310*		93.53
2024-12-05	BUY	14			93.730*		93.53
2024-12-04	BUY	70			94.220*		93.50
2024-11-29	BUY	70			96.680*		93.29
2024-11-27	BUY	56			96.760*		92.99
2024-11-26	BUY	14			96.300*		92.84
2024-11-21	BUY	70			92.730*		92.59
2024-11-20	BUY	42			91.170*		92.67
2024-11-18	BUY	168			87.690*		93.08
2024-11-12	BUY	112			90.990*		93.22
2024-11-08	BUY	70			95.420*		93.06
2024-11-07	BUY	210			94.090*		92.98
2024-11-06	BUY	28			94.090*		92.89
2024-10-31	BUY	14			88.490*		94.45

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NUVL

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer